Quantitative determination of mithramycin in human plasma by a novel, sensitive ultra-HPLC-MS/MS method for clinical pharmacokinetic application.
about
Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma CellsPlasma protein binding monitoring of therapeutic drugs in patients using single set of hollow fiber centrifugal ultrafiltration.A phase I/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS-FLI1 fusion transcript.
P2860
Quantitative determination of mithramycin in human plasma by a novel, sensitive ultra-HPLC-MS/MS method for clinical pharmacokinetic application.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Quantitative determination of ...... l pharmacokinetic application.
@ast
Quantitative determination of ...... l pharmacokinetic application.
@en
Quantitative determination of ...... l pharmacokinetic application.
@nl
type
label
Quantitative determination of ...... l pharmacokinetic application.
@ast
Quantitative determination of ...... l pharmacokinetic application.
@en
Quantitative determination of ...... l pharmacokinetic application.
@nl
prefLabel
Quantitative determination of ...... l pharmacokinetic application.
@ast
Quantitative determination of ...... l pharmacokinetic application.
@en
Quantitative determination of ...... l pharmacokinetic application.
@nl
P2093
P2860
P1476
Quantitative determination of ...... l pharmacokinetic application.
@en
P2093
Brigitte Widemann
Cody J Peer
David Schrump
Diane E Cole
Jeffrey Roth
Lee Helman
Rachel Ershler
William D Figg
P2860
P304
P356
10.1016/J.JCHROMB.2014.08.021
P577
2014-09-06T00:00:00Z